James A McNulty insider trades
Open-market stock purchases and sales by James A McNulty, Chief Financial Officer at Inhibitor Therapeutics, Inc, from SEC Form 4 filings since Mar 25, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 1, 2026 | INTI Inhibitor Therapeutics, Inc | Sold (not open market) | — |
Companies traded
- INTI Inhibitor Therapeutics, Inc: other filings, last Jul 1, 2026
- RENB Renovaro Inc: other filings, last Nov 4, 2024
- CVSI CV Sciences, Inc: other filings, last Jun 16, 2020
- CANV CV Sciences, Inc: other filings, last Feb 5, 2018
- BDSI Biodelivery Sciences International Inc: 2 buys, 12 sales, last Jan 24, 2014